AlmataBio Acquired by Avalo Therapeutics | Healthcare M&A Deal

Avalo Therapeutics has completed the acquisition of AlmataBio, a healthcare services other business in Pennsylvania, for $15,000,000. Avalo Therapeutics acquisitions focus on expanding healthcare M&A capabilities by adding AlmataBio’s healthcare services operations and related clinical and commercial execution in PA acquisitions. AlmataBio acquisition supports Avalo Therapeutics’ strategic acquisition strategy in healthcare deals PA, strengthening its platform for future growth. The add on acquisition is structured as an add on acquisition with strategic buyer participation, with milestone-based consideration mechanics including $2,250,000, $5,125,000, and $12,750,000 tied to achievement of the third milestone buyout option.